Fractional exhaled nitric oxide and the response to prednisolone for asthma attacks in patients treated with anti-IL5/5Rα therapy: a prospective observational study
Imran Howell(Institute of Cancer Research), Ian Pavord(Oxford BioMedica (United Kingdom)), Sanjay Ramakrishnan(Oxford BioMedica (United Kingdom)), Timothy Hinks(University of Oxford), J. Mark Melhorn(University Hospital of Wales), Catherine Borg(University of Oxford), Mahdi Mahdi(National Institute for Health and Care Research), Gabriel Lavoie(Université de Montréal), Nayia Petousi(University of Oxford), Hafiz Taha Mahmood(The University of Western Australia), Laura Bermejo-Sanchez(University of Oxford), Mona Bafadhel(National Institute for Health and Care Research)
Cited by 5
Related Papers
Effectiveness and Safety of Bronchial Thermoplasty in the Treatment of Severe Asthma: A Multicenter, Randomized, Double-Blind, Sham-Controlled Clinical Trial
|American Journal of Respiratory and Critical Care Medicine|2009|686
Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study
|The Lancet Respiratory Medicine|2015|584
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts
|New England Journal of Medicine|2023|452
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial
|The Lancet Respiratory Medicine|2021|434
Benralizumab for the Prevention of COPD Exacerbations
|New England Journal of Medicine|2019|329